|

Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons

RECRUITINGN/ASponsored by Kessler Foundation
Actively Recruiting
PhaseN/A
SponsorKessler Foundation
Started2022-12-08
Est. completion2027-09
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

Approximately 5.3 million people live with a long-term disability resulting from a traumatic brain injury (TBI) and between 5-8% of those older than 60 suffer from Alzheimer's disease or other forms of dementia (ADRD). Consequences of these conditions can result in dramatic and persistent changes in functioning, impacting not only the patients, but also loved ones who become informal support persons. Many existing services help the family in the moment, but do not address long-term wellness. Thus, the purpose of this research study is to compare the effect of two different types of group wellness treatments for individuals with chronic mild TBI, moderate to severe TBI, and ADRD and their support persons.

Eligibility

Age: 18 Years+Healthy volunteers accepted
For individuals with moderate/severe TBI:

Inclusion Criteria:

* age 18-70
* at least 4 months post injury
* can read and speak English fluently
* has a support person who is willing to participate in the study

Exclusion Criteria:

* has had a prior stroke or neurological disease other than TBI
* has unstable or uncontrolled seizures
* has been hospitalized due to a significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) in the past three months
* current alcohol and/or drug use that interferes with ability to carry out common everyday functions

For individuals with chronic mild TBI:

Inclusion Criteria:

* age 18-70
* at least 3 months post-injury
* can read and speak English fluently
* has a support person who is willing to participate in the study

Exclusion Criteria:

* has had a prior stroke or neurological disease other than mild TBI
* has unstable or uncontrolled seizures
* has been hospitalized due to a significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) in the past three months
* current alcohol and/or drug use that interferes with ability to carry out common everyday functions

For Individuals with Alzheimer's Disease Related Dementias (ADRD)

Inclusion Criteria:

* age 65 and older
* at least one-year post-diagnosis
* can read and speak English fluently
* has a support person who is willing to participate in this study

Exclusion Criteria:

* has had a prior stroke or neurological disease other than ADRD
* has unstable or uncontrolled seizures
* has been hospitalized due to a significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) in the past three months
* current alcohol and/or drug use that interferes with ability to carry out common everyday functions

For Support Persons:

Inclusion Criteria:

* is the support person of an individual with moderate/severe TBI, chronic mild TBI or ADRD who is willing to participate in the study
* can read and speak English fluently

Exclusion Criteria:

* has a significant neurological history (e.g. stroke or multiple sclerosis)
* has unstable or uncontrolled seizures
* has been hospitalized due to a significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) in the past three months
* current alcohol and/or drug use that interferes with ability to carry out common everyday functions

Conditions6

Alzheimer's DiseaseBrain Injury Traumatic ModerateBrain Injury Traumatic SevereDementiaMild Traumatic Brain InjuryTraumatic Brain Injury

Locations1 site

Kessler Foundation
East Hanover, New Jersey, 07936
Matthew Weiner973-324-3515mweiner@kesslerfoundation.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.